Animal anatomy

Dr. Leo Indianer and (833) 4LA-SKIN Have Announced the Addition of INFINI™ for Acne Scars and Wrinkle Reduction

Retrieved on: 
Wednesday, January 8, 2020

ENCINO, Calif., Jan. 8, 2020 /PRNewswire/ -- Dr. Leo Indianer and 1-833 4LA-SKIN are excited to announce the latest addition to Encino's premier dermatology practice, INFINI.

Key Points: 
  • ENCINO, Calif., Jan. 8, 2020 /PRNewswire/ -- Dr. Leo Indianer and 1-833 4LA-SKIN are excited to announce the latest addition to Encino's premier dermatology practice, INFINI.
  • This unique High Intensity Focused RF device is specially developed for wrinkle reduction and acne scars through 3-D volumization; it maximizes results while minimizing patient discomfort.
  • Infini provides a long overdue solution for dark or tanned skinned patients, who until now had limited energy-based treatment choices.
  • "We have added Infini to our suite of lasers," stated board certified dermatologist, Dr. Leo Indianer, "because of all of the extraordinary benefits involving wrinkle reduction and acne treatment.

Global Medical Exoskeleton Market 2020-2024| Evolving Opportunities with Bioness Inc. and Bionik Laboratories Corp. | Technavio

Retrieved on: 
Monday, January 6, 2020

Technavio has been monitoring the global medical exoskeleton market and the market is poised to grow by USD 351.68 million during 2020-2024 at a CAGR of almost 29% during the forecast period.

Key Points: 
  • Technavio has been monitoring the global medical exoskeleton market and the market is poised to grow by USD 351.68 million during 2020-2024 at a CAGR of almost 29% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20200106005640/en/
    Technavio has announced its latest market research report titled global medical exoskeleton market 2020-2024 (Photo: Business Wire)
    Read the 139-page research report with TOC on "Medical Exoskeleton Market Analysis Report by Geography (Asia, Europe, North America, and ROW), by Mobility type (Mobile exoskeleton and Stationary exoskeleton), and Segment Forecasts, 2020-2024".
  • The advantages of medical exoskeletons in rehabilitation and the growing focus on development of 3D-printed medical exoskeletons is anticipated to boost the growth of the market.
  • Thus, the advantages of medical exoskeletons in rehabilitation are expected to drive market growth during the forecast period.

Makeup Tips for Acne-Prone Skin: American Academy of Dermatology

Retrieved on: 
Tuesday, December 10, 2019

As the holidays approach and people start preparing for parties and other festivities, dermatologists from the American Academy of Dermatology say its okay for acne patients to wear makeup.

Key Points: 
  • As the holidays approach and people start preparing for parties and other festivities, dermatologists from the American Academy of Dermatology say its okay for acne patients to wear makeup.
  • To wear makeup on acne-prone skin, Dr. Kazin recommends the following tips:
    Choose makeup carefully.
  • Instead, use makeup applicators, such as brushes, to apply makeup directly to your skin.
  • These tips are demonstrated in Makeup Tips for Acne-Prone Skin , a video posted to the AAD website and YouTube channel .

Global $5.12 Bn Acne Treatment Market Opportunities and Forecast to 2024

Retrieved on: 
Wednesday, December 4, 2019

DUBLIN, Dec. 4, 2019 /PRNewswire/ -- The "Global Acne Treatment Market: World Market Review By Product Type, Applications, By Region, By Country (2019 Edition): Opportunities and Forecast (2019-2024) - By Country (USA, Canada, Germany, France, UK, Italy, Spain, China, India, Mexico)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 4, 2019 /PRNewswire/ -- The "Global Acne Treatment Market: World Market Review By Product Type, Applications, By Region, By Country (2019 Edition): Opportunities and Forecast (2019-2024) - By Country (USA, Canada, Germany, France, UK, Italy, Spain, China, India, Mexico)" report has been added to ResearchAndMarkets.com's offering.
  • Global acne market has gained importance and is expected to see huge growth due to rising disposable income, high global prevalence, unhealthy eating habits and adoption of less painful aesthetic combination therapy procedures.
  • Additionally, rising advancements in dermatology and existence of seamless industry for skincare is backing the growth of acne treatment market.
  • Moreover, increasing adoption of innovative acne treatment technologies to cure mild to severe acne in North America countries has been impelling the market growth.

Global Acne Treatment Market Opportunities and Forecast 2019-2024: Review By Product Type, Applications, Region, Country - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 3, 2019

The "Global Acne Treatment Market: World Market Review By Product Type, Applications, By Region, By Country (2019 Edition): Opportunities and Forecast (2019-2024) - By Country (USA, Canada, Germany, France, UK, Italy, Spain, China, India, Mexico)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Acne Treatment Market: World Market Review By Product Type, Applications, By Region, By Country (2019 Edition): Opportunities and Forecast (2019-2024) - By Country (USA, Canada, Germany, France, UK, Italy, Spain, China, India, Mexico)" report has been added to ResearchAndMarkets.com's offering.
  • Global acne market has gained importance and is expected to see huge growth due to rising disposable income, high global prevalence, unhealthy eating habits and adoption of less painful aesthetic combination therapy procedures.
  • Additionally, rising advancements in dermatology and existence of seamless industry for skincare is backing the growth of acne treatment market.
  • Moreover, increasing adoption of innovative acne treatment technologies to cure mild to severe acne in North America countries has been impelling the market growth.

BiomX Announces Completion of Enrollment for Double-Blind, Placebo-Controlled Clinical Study of BX001 in Acne-Prone Skin

Retrieved on: 
Monday, December 2, 2019

Exploratory endpoints include proof of principle by measurement of the effect of BX001 on C. acnes levels.

Key Points: 
  • Exploratory endpoints include proof of principle by measurement of the effect of BX001 on C. acnes levels.
  • BX001 comprises phage that target specific bacteria and has the potential for efficient rebalancing of the skin microbiome, said Jonathan Solomon, CEO of BiomX.
  • BiomX enrolled 75 individuals with mild-to-moderate acne in the ongoing cosmetic clinical study of BX001.
  • For BX001 studies in acne-prone skin, BiomX is working in collaboration with a leading multinational cosmetic company.

Lansinoh Announces Launches of Organic Nipple Balm and Smartpump 2.0

Retrieved on: 
Monday, December 2, 2019

ALEXANDRIA, Va., Dec. 2, 2019 /PRNewswire/ -- Lansinoh , a global leader in the breastfeeding market, today announced the launch of two new breastfeeding products: Organic Nipple Balm and Smartpump 2.0.

Key Points: 
  • ALEXANDRIA, Va., Dec. 2, 2019 /PRNewswire/ -- Lansinoh , a global leader in the breastfeeding market, today announced the launch of two new breastfeeding products: Organic Nipple Balm and Smartpump 2.0.
  • From the makers of the #1 nipple cream brand recommended by moms and doctors in the US, comes Lansinoh's new Organic Nipple Balm .
  • Made with organic argan and coconut oils to help moisturize and soothe tender nipples, Organic Nipple Balm is a silky smooth formula that is easy to apply and gentle on sensitive skin.
  • Organic Nipple Balm retails for $15.99 on Amazon and Target , and Smartpump 2.0 retails for $169.99 on Amazon .

Management of Temporomandibular Disorders and Occlusion, 8th Edition - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 28, 2019

The "Management of Temporomandibular Disorders and Occlusion.

Key Points: 
  • The "Management of Temporomandibular Disorders and Occlusion.
  • Covering both emerging and proven techniques in this dynamic area of oral health, Management of Temporomandibular Disorders and Occlusion, 8th Edition is the only textbook that guides you from basic anatomy and function to providing solutions to many common occlusal and TMD problems.
  • Clear descriptions and a new full-color design promote a complete understanding of normal, abnormal, and dysfunctional occlusal relationships and masticatory function and dysfunction.
  • Determinants of Occlusal Morphology
    Part II: Etiology Considerations of Temporomandibular Disorders 7.

Martha Barretto-Escalera, R.N. is recognized by Continental Who's Who

Retrieved on: 
Monday, November 18, 2019

BAKERSFIELD, Calif., Nov. 18, 2019 /PRNewswire/ --Martha Barretto-Escalera, R.N., is being recognized by Continental Who's Who as a Pinnacle Lifetime Achiever in the field of Aesthetics as Co-Owner and Registered Nurse at Reveal Medical Aesthetics, Inc.

Key Points: 
  • BAKERSFIELD, Calif., Nov. 18, 2019 /PRNewswire/ --Martha Barretto-Escalera, R.N., is being recognized by Continental Who's Who as a Pinnacle Lifetime Achiever in the field of Aesthetics as Co-Owner and Registered Nurse at Reveal Medical Aesthetics, Inc.
  • Reveal Medical Aesthetics offers customers numerous cosmetic services, including chemical peels, laser hair removal, anti-aging treatments, acne treatments, and skin care services.
  • The staff at the office is dedicated to helping customers accomplish personal goals, while providing a warm and comfortable environment.
  • Customers have rated the office five stars on the business directory service Yelp, praising the office's skills, prices, training, and atmosphere.

ExCellThera announces publication in The Lancet Haematology highlighting excellent clinical results of ECT-001 in patients with haematological malignancies

Retrieved on: 
Wednesday, November 6, 2019

The data were published in the peer-reviewed medical journal, The Lancet Haematology.

Key Points: 
  • The data were published in the peer-reviewed medical journal, The Lancet Haematology.
  • Were pleased that these important results from the first clinical trial using ECT-001 in haematological malignancies are now fully available to the broader bone marrow transplant community, said Dr.
  • ExCellThera also plans to initiate a European clinical trial as well as a pivotal, multi-centre clinical trial in the coming months.
  • excellthera.com
    Contacts: David Millette Chief Operating and Financial Officer, ExCellThera [email protected] Lisa Willemse Chief Marketing Officer, ExCellThera [email protected]